| abstract |
The present invention generally relates to a number of compounds, to pharmaceutical compositions containing these compounds, as well as to the use of these compounds and compositions as therapeutic agents. In particular, the compounds according to the present invention are benzazepine compounds. These compounds are ligands of serotonin receptors (5-HT) and are suitable for the treatment of diseases, disorders and pathological conditions that require modulation of the activity of serotonin receptors (5-HT) (for example, dependence, anxiety, depression, obesity, etc.). |